Dhanonjoy C. Saha, DVM, PhD Director, Office of Grant Support (OGS) December 16 and 17, 2015.
-
Upload
chester-logan -
Category
Documents
-
view
216 -
download
0
description
Transcript of Dhanonjoy C. Saha, DVM, PhD Director, Office of Grant Support (OGS) December 16 and 17, 2015.
Upcoming Changes in NIH Policies and Procedures in Grant
Application
Dhanonjoy C. Saha, DVM, PhDDirector, Office of Grant Support
(OGS)
December 16 and 17, 2015
Introduction
Who we are? What do we do?
What are our roles and responsibilities?
What are the recent changes?
What is Office of Grant Support?
The Office of Grant Support (OGS) is comprised of only three individuals who provide pre-award administrative assistance to the College community
Our goal is to enable faculty scholars to
submit grant proposals and to manage subsequent non-financial responsibilities of the award, resubmission, and renewal processes
What Do We Do?
Help develop or review proposal budgets Review and ensure pre-submission regulatory
requirements Help with creating and managing electronic
grant submissions Assist with required registrations for
submissions Help with submissions of grant proposals to
granting agencies or sponsors Negotiate budgets and other related terms and
conditions of the awards with the sponsors
What Do We Do? …
Manage Awards Committee nominations (for limited submissions)
Help with submission of non-competing applications, Just-in-Time, Supplemental Materials, RPPR and ….
Assist with communications or communicate with grant-making agencies
Help with preparing and submitting Final Invention Statements
Help with finding resources for improving grant applications
eRA Manager AOR (Authorized Organizational Representative),
SO (Signing Official) Application assembly and submission Application withdrawal request Cayuse System primary contact – User ID,
password, application unlock eRA Commons issues related to submission eRA Commons back up for Cynthia Cardillo –
User ID, password Final Invention Statement Grants.gov account and related issue
eRA Manager… Just-in-time submission Limited submission application management Post-submission material and communication No Cost Extension NYS Grants Gateway User ID Compliance communication with sponsors (IRB,
IACUC, IBC) OPAS submission Other (all Federal) electronic submission portal
User ID, password and task
Pre-award Analyst AOR, SO Budget development, review and budget revisions (pre-
award only) Budget review for No Cost Extension Collaboration letter review and preparation for signature Face page review and processing for signature Indirect cost reduction/waiver, no salary support request
processing Letter of Intent (LOI) and Statement of Work (SOW)
review and processing Other (all non-federal including NYS Grants Gateway)
electronic submission portal User ID, password and submission
RPPR (Research Performance Progress Report) review and submission via eRA Commons
Director AOR, SO, Business Official Agreement and contract negotiation with
sponsor Funding Opportunities Grant Development NYS Grants Gateway submission and approval Any other tasks and items related to pre-award
application management
What Can We Do?
Find funding opportunities -- small or large grants -- state, federal, private, foundation
Target dissemination of funding opportunities to interested trainees and faculty members
Interpret proposal guidelines and help with building application materials-- eligibility, forms, institutional data
Grantsmanship: assist with team-building, writing, editing, proofreading, proposal review and critique and creating more competitive proposals
Visit us at - http://www.einstein.yu.edu/administration/grant-support/
Upcoming Changes in NIH SubmissionNOT-OD-16-004; NOT-OD-16-011
Administrative and Scientific Two Phases of Implementation
Rigor and transparency in research Vertebrate animals Inclusion reporting Data safety monitoring Research training Appendices Font requirements Bio-sketch clarifications
Implementations and Deadlines
Using existing (FORM-C) forms and updated instructions and will impact due dates on or after January 25, 2016
New form (FORM-D) and instructions and will impact due dates on or after May 25, 2016
Phase I - January 25, 2016
Still using the existing Form C Additional requirements in research strategy Rigor and Transparency – key areas:
The scientific premise of the research Rigorous experimental design for unbiased results Consideration of relevant biological variables Authentication of Key Biological and or Chemical
Resources Additional rigor and transparency questions will
be considered by reviewers Authentication of Key Biological and or Chemical
Resources PDF attachment need to be uploaded
Rigor and TransparencyNOT-OD-16-011
The four areas of focus shall apply to the full spectrum of research, from basic to clinical -- need to consider how all four areas apply to the proposed research
Reviewers will assess whether these areas have been appropriately addressed by the applicant
Exceptions: Research grant activity codes excluded from this policy
include C06, G08, G11, G12, G13, G20, R13, S06, S10, S21, SB1, U13, U55, UB1, UC6, UC7, UG4, UH4, X02, and 333.
RRRGs or components (P30, P40, P41, P2C, R24, R28, U24, U41, U42,U2C) may have slightly revised review language
Career Development Award application instructions and review language – implementation date, May 25, 2016 (NOT-OD-16-012)
Research StrategyInstructions will be updated to include the following additional guidance for the Significance and Approach sections of the Research Strategy Significance: Description of the scientific premise for the
proposed project, including consideration of the strengths and weaknesses of published research or preliminary data
Approach: Description of the experimental design and methods proposed and how they will achieve robust and unbiased results
Explanation of how relevant biological variables, such as sex, are factored into research designs and analyses for studies in vertebrate animals and humans For example, strong justification from the scientific literature, preliminary
data, or other relevant considerations, must be provided for applications proposing to study only one sex (see NOT-OD-15-102 for NIH expectations about sex as a biological variable)
Scientific Premise and Scientific Rigor The scientific premise: The general strengths and
weaknesses of the prior research cited by the applicant, which form the basis for the proposed research -- expected that this would include attention to the rigor of the previous experimental designs, as well as the incorporation of relevant biological variables and authentication of key resources
The scientific premise will be reviewed as part of the Significance criterion, i.e., the importance of the problem, critical barriers to progress, how the proposed project will improve scientific knowledge, and how the field will change if the aims are achieved
Scientific Premise and Scientific Rigor… Scientific rigor: Strict application of the
scientific method to ensure robust and unbiased experimental design, methodology, analysis, interpretation and reporting of results -- full transparency would help reproducibility of the findings
Robust and Unbiased: Using methods to reduce bias -- such as having multiple individuals recording assessments, using independent, blinded assessors, etc. These are goals, not absolute standards to be met, and may vary across scientific disciplines
Authentication of Key Biological and/or Chemical Resources
Briefly describe methods to ensure the identity and validity of key biological and/or chemical used/proposed in the studies. These may or may not be generated with NIH funds
These include, but are not limited to, cell lines, specialty chemicals, antibodies, and other biologics
Use the FORM-C forms. PDF and upload document (titled "Authentication of Key Resources Plan") in the "Other Attachments" section of the "Other Project Information" form
Application Review
Reviewers will be asked to consider additional review questions in order to assess rigor and transparency
Scored Review Criteria Significance: Is there a strong scientific premise for the
project? Approach:
Have the investigators presented strategies to ensure a robust and unbiased approach?
Have the investigators presented adequate plans to address relevant biological variables, such as sex, for studies in vertebrate animals or human subjects?
Additional Review Considerations Authentication of Key Biological and/or Chemical Resources
For projects involving key biological and/or chemical resources, reviewers will comment on the brief plans proposed for identifying and ensuring the validity of those resources
Vertebrate Animals
Updated guidance on criteria to be addressed including justifications, minimization of pain and distress and euthanasia
Description of veterinary care and justification of the number of animals will no longer be required
A description of the method of euthanasia is required only if the method is not consistent with AVMA guidelines
Vertebrate Animals Application Review Criteria
As applicable for the project proposed, reviewers will evaluate the involvement of live vertebrate animals as part of the scientific assessment according to the following criteria: (1) description of procedures involving animals including
species, strains, ages, sex and total number to be used; (2) justifications for the use of animals versus alternative
models and for the appropriateness of the species proposed;
(3) interventions to minimize discomfort, distress, pain and injury; and
(4) justification for the euthanasia method if not consistent with the AVMA Guidelines for the Euthanasia of Animals
Definition of Child
Will now mean under 18 years old rather than under 21
Must include a plan of how children will be used in human subject research or why not if they won’t be used
Research Training
Recruitment and retention to increase diversity—emphasis will be recruitment
Human subjects—explanation needed that trainees will only participate in IRB-approved or exempt research
Vertebrate animals -- description needed that trainees will only participate in IACUC-approved vertebrate animal research
xTRACT electronic system for creating research training data tables was created and will be available
Phase 2 - May 25, 2016 A new Form FORM-D will be required Rigor and Transparency
Institutional training and individual fellowship applications will be included
The PHS 398 Research Plan form will include a new "Authentication of Key Biological and/or Chemical Resources" attachment field
Vertebrate Animals Institutional training and individual fellowship applications
will be included New questions regarding euthanasia will replace the current
Inclusion Forms A new optional form will be added—details to come
Inclusion Form
An optional PHS Inclusion Enrollment Report form to FORM-D will be added to the application packages
The new form, with additional study descriptors, will replace the optional Planned Enrollment Report and Cumulative Inclusion Enrollment Report forms found in FORM-C application packages
Details are upcoming
Phase 2 - May 25, 2016… Data Safety Monitoring Plans:
New Data Safety Monitoring Plan will be required (Form D) with applications involving clinical trials
Research Training:
Research training data table will reduce tables to 8 and extend trainee outcome tracking from ten years to fifteen
New optional PHS assignment request form:
Will allow collection of requests for preference of awarding component, study section, potential reviewers in conflict and scientific expertise needed
New Font guidelines Font must be 11 points or larger Type density must be no more than 15
characters per linear inch (including characters and spaces)
Line spacing must be no more than six lines per vertical inch
Recommended fonts are: Arial, Garamond, Georgia, Helvetica, Palatino Linotype, Times New Roman, and Verdana
Bio-sketch A URL for a publication list is optional and,
if provided, must be to a government website (.gov) like My Bibliography
Publications (peer-reviewed and non-peer-reviewed) and research products can be cited in both the personal statement and the contributions to science sections
Graphics, figures and tables are not allowed
New PHS Assignment Request FormNOT-OD-16-008
An optional PHS Assignment Request Form to
FORM-D application packages to provide a consistent way to collect application referral information, including:
Awarding component (NIH Institute) assignment preference
Study Section preference List of potential reviewers in conflict, and why List of scientific expertise needed to review the
application
Font Size, Type Density and Spacing Font size: must be 11 points or larger (smaller text in
figures, graphs, diagrams and charts is acceptable as long as it is legible when the page is viewed at 100%)
Type density: must be no more than 15 characters per linear inch (including characters and spaces)
Line spacing: must be no more than six lines per vertical inch
The following fonts are recommended: Arial Garamond Georgia Helvetica Palatino Linotype Times New Roman Verdana
Research Performance Progress Reports
Research Performance Progress Reports
(RPPR) submitted January 25, 2016 or later will be expected to emphasize rigorous approaches taken to ensure robust and unbiased results. Rigor should be addressed in the RPPR for any grant that funds research or training in research.
This includes non-competing continuation reports (Type 5) for grants reviewed and awarded before implementation of the policy.
Thank You
For general information, please contact the Office of Grant Support at (718) 430-3643 or [email protected]
For pre-award budget -- Gerard McMorrow at (718) 430-3580 or [email protected]
For Cayuse, eRA Commons and any other help -- Regina Janicki at (718) 430-3643 or [email protected]
For any other help -- D. C. Saha at (718) 430-3642 or [email protected]
Any Questions?